MedPath

Effects of adding budesonide/formoterol in patients with COPD

Not Applicable
Conditions
Chronic obstructive pulmonary disease (COPD)
Registration Number
JPRN-UMIN000008394
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

MDCT demonstrated budesonide/formoterol induced bronchodilation in the non-small airway. CT imaging can evaluate drug therapeutic effect and may provide additional insights into pharmacotherapy for COPD.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

History of hyper-sensitivity to budesonide/formoterol Patients with bronchial asthma Patients during acute exacerbation Presence of infectious disease, pneumothorax, and severe heart failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath